NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/25/2025
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Case type
Recorded events
Latest update
Classification
Trademark type
Nice classes
Filing date
Registration date
Expiration date
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Structured fields from the responsible authority and the official record.
Status date
Last transaction
Responsible office
Status code
Official register
Filing basis
First use anywhere
First use in commerce
Drawing code
Owner type
Owner location
Examiner
Law office
Current location
Mark description
The mark consists of the stylized letters "UBIP." A stylized globe forms a portion of the letter "P" in "UBIP".
Holders
Representatives
Joe McKinney Muncy MUNCY, GEISSLER, OLDS & LOWE, P.C.
Nice Classes
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Antibiotics; Pre-filled syringes for medical purposes being syringes sold filled with pharmaceutical preparations for the treatment of cancers, infections, metabolic diseases, and neurological disorders; Medicines for human purposes for the treatment of cancers, infections, metabolic diseases, and neurological disorders; Contrast medium for medical use being contrast media for in vivo imaging; Ointments for pharmaceutical purposes being anti-biotic, anti-infective, and anti-inflammatory ointments; Poultices for pharmaceutical purposes being anti-biotic, anti-infective, and anti-inflammatory poultices; Western medicine, namely, pharmaceutical preparations for the treatment of cancers, infections, metabolic diseases, and neurological disorders; Active pharmaceutical ingredients (APIs) for Western Medicine being pharmaceutical preparations for the treatment of cancers, infections, metabolic diseases, and neurological disorders; Vitamin preparations; antiviral drug; biological preparations for medical purposes being biological preparations for the treatment of cancers, infections, metabolic diseases, neurological disorders; Hormones for medical purposes; Medicated skin lotions for pharmaceutical purposes; Medicinal drinks; Vaccines; chemico-pharmaceutical preparations for the treatment of cancers, infections, metabolic diseases, neurological disorders; Albuminous preparations for medical purposes, namely, pharmaceutical preparations featuring albumin peptides, proteins and complexes thereof for the treatment of cancers, infections, metabolic diseases, and neurological disorders; biological reagent for medical purposes; test reagent for medical purposes; Diagnostic preparations for medical purposes; Diagnostic biomarker reagents for medical purposes
Class 42
Providing research and development in the field of biological and pharmaceutical scientific research and development; Biological research; Bacteriological research; Clinical lab test of medical reagent being providing reagent sample testing for others for scientific research purposes; Clinical trials, namely, scientific research in the nature of conducting clinical trials for others; Research and analysis of medical reagent being medical research; medical research; Research and development of new products for others; Technical project studies being conducting of feasibility studies in the field of new technologies; Technical writing; Industrial analysis and research service in the field of pharmaceutical sciences; Rental of laboratory instruments; Scientific laboratory services; Technological consultancy in the field of biological and pharmaceutical manufacturing processes; scientific research and technological research in the field of biological and pharmaceutical manufacturing processes; culturing of cells for others for scientific research purposes
History of USPTO decisions and trademark events.
41 publications found
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/25/2025
REGISTERED-PRINCIPAL REGISTER
03/25/2025
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/03/2025
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/03/2025
TEAS/EMAIL CORRESPONDENCE ENTERED
02/14/2025
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/14/2025
TEAS REQUEST FOR RECONSIDERATION RECEIVED
02/14/2025
NOTIFICATION OF FINAL REFUSAL EMAILED
11/15/2024
FINAL REFUSAL E-MAILED
11/15/2024
SU - FINAL REFUSAL - WRITTEN
11/15/2024
TEAS/EMAIL CORRESPONDENCE ENTERED
10/22/2024
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/22/2024
ASSIGNED TO LIE
10/22/2024
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/11/2024
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/12/2024
NON-FINAL ACTION E-MAILED
04/12/2024
SU - NON-FINAL ACTION - WRITTEN
04/12/2024
STATEMENT OF USE PROCESSING COMPLETE
03/16/2024
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/11/2024
USE AMENDMENT FILED
02/20/2024
TEAS STATEMENT OF USE RECEIVED
02/20/2024
ASSIGNED TO EXAMINER
10/23/2023
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/12/2023
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/18/2023
PUBLISHED FOR OPPOSITION
07/18/2023
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/28/2023
APPROVED FOR PUB - PRINCIPAL REGISTER
06/08/2023
EXAMINER'S AMENDMENT ENTERED
06/08/2023
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/08/2023
EXAMINERS AMENDMENT E-MAILED
06/08/2023
EXAMINERS AMENDMENT -WRITTEN
06/08/2023
TEAS/EMAIL CORRESPONDENCE ENTERED
05/09/2023
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/09/2023
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/09/2023
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/11/2023
NON-FINAL ACTION E-MAILED
04/11/2023
NON-FINAL ACTION WRITTEN
04/11/2023
ASSIGNED TO EXAMINER
04/04/2023
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/12/2022
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/11/2022
NEW APPLICATION ENTERED
06/25/2022
Continuous trademark protection
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.